Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that ...
Myriad Genetics (MYGN) announced a study revealing that more patients completed hereditary cancer testing when they used an online screening ...
In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...
A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data ...
Mysterious Blobs Found inside Cells Are Rewriting the Story of How Life Works Tiny specks called biomolecular condensates are ...
Creative Biolabs The exosome services offered by Creative Biolabs undergo new developments in exosome sampling, isolation, purification, an ...
News Medical on MSN21h
CDC report reveals COPD as the sixth leading cause of death in the U.S.Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...
Companion Cancer Diagnostics Market The rising incidence of cancer worldwide is a primary driver of the Global Companion Cancer Diagnostics ...
CBS News New York's Natalie Duddridge leads team coverage of Mr. Trump's second day in office. Former president George W.
Sen. Adam Schiff (D-Calif.) called his preemptive pardon from former President Biden, announced Monday for all past members ...
This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback